Human melanocyte senescence and melanoma susceptibility genes

Oncogene

Volumn 22, Issue 20, 2003, Pages 3063-3069

  Bennett, Dorothy C ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

CDK4; Genetics; Melanoma; Pl6INK4A; Progression; Senescence

Indexed keywords

CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR;

ARF GENE; CANCER GENETICS; CANCER GROWTH; CANCER SUSCEPTIBILITY; CELL GROWTH; CELL IMMORTALIZATION; CELL LINEAGE; CELL SURVIVAL; FIBROBLAST; GENE; GENE SEQUENCE; GENETIC SUSCEPTIBILITY; HUMAN; INK4A GENE; MELANOCYTE; MELANOMA; PRIORITY JOURNAL; REVIEW; SENESCENCE;

ANIMALS; APOPTOSIS; CELL AGING; CELL LINE, TRANSFORMED; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASES; DISEASE PROGRESSION; GENES, P16; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MELANOCYTES; MELANOMA; MICE; PROTO-ONCOGENE PROTEINS; RETINOBLASTOMA PROTEIN; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P14ARF;

EID: 0038457477     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206446     Document Type: Review

References (57)

1. Alani RM, Young AZ and Shifflett CB. (2001). Proc. Natl. Acad. Sci. USA, 98, 7812-7816.
2. Alcorta DA, Xiong Y, Phelps D, Hannon G, Beach D and Barrett JC. (1996). Proc. Natl. Acad. Sci. USA, 93, 13742-13747.
3. Artandi SE and DePinho RA. (2000). Curr. Opin. Genet. Dev., 10, 39-46.
4. Bandyopadhyay D, Timchenko N, Suwa T, Hornsby PJ, Campisi J and Medrano EE. (2001). Exp. Gerontol., 36, 1265-1275.
5. Bartkova J, Lukas J, Guldberg P, Alsner J, Kirkin AF, Zeuthen J and Bartek J. (1996). Cancer Res., 56, 5475-5483.
6. Bastiaens M, ter Huurne J, Gruis N, Bergman W, Westendorp R, Vermeer B-J and Bouwes Bavinck JN. (2001). Hum. Mol. Genet., 10, 1701-1708.
7. Bennett DC. (1989). Environ. Health Persp., 80, 49-60.
8. Bennett DC and Medrano EE. (2002). Pigment Cell Res., 15, 242-250.
9. Bennett DC, Bridges K and McKay IA. (1985). J. Cell Sci., 77, 167-183.
10. Blackburn EH. (2000). Nature, 408, 53-56.
11. Brookes S, Rowe J, Ruas M, Llanos S, Clark PA, Lomax M, James MC, Vatcheva R, Bates S, Vousden KH, Parry D, Gruis N, Smit N, Bergman W and Peters G. (2002). EMBO J., 21, 2936-2945.
12. Buscà R and Ballotti R. (2000). Pigment Cell Res., 13, 60-69.
13. Clark WH, Elder DE, Guerry D, Braitman LE, Trock BJ, Schultz D, Synnestvedt M and Halpern AC. (1989). J. Natl. Cancer Inst., 81, 1893-1904.
14. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JW, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR and Futreal PA. (2002). Nature, 417, 949-954.
15. Easty DJ and Bennett DC. (2000). Melanoma Res., 10, 401-411.
16. Eisinger M and Marko O. (1982). Proc. Natl. Acad. Sci. USA, 79, 2018-2022.
17. Gilchrest BA, Vrabel MA, Flynn E and Szabó G. (1984). J. Invest. Dermatol., 96, 370-376.
18. Glaessl A, Bosserhoff AK, Buettner R, Hohenleutner U, Landthaler M and Stolz W. (1999). Arch. Dermatol. Res., 291, 81-87.
19. Goding CR. (2000). Genes Dev., 14, 1712-1728.
20. Graeven U and Herlyn M. (1992). J. Immunother., 12, 199-202.
21. Haddad MM, Xu W and Medrano EE. (1998). J. Invest. Dermatol. Symp. Proc., 3, 36-40.
22. Haddad MM, Xu W, Schwahn DJ, Liao F and Medrano EE. (1999). Exp. Cell Res., 253, 561-572.
23. Halaban R, Pomerantz SH, Marshall S, Lambert DT and Lerner AB. (1983). J. Cell Biol., 97, 480-488.
24. Halaban R, Ghosh S, Duray P, Kirkwood JM and Lerner AB. (1986). J. Invest. Dermatol., 87, 95-101.
25. Halaban R, Cheng E, Smicun Y and Germino J. (2000). J. Exp. Med., 191, 1005-1016.
26. Halachmi S and Gilchrest BA. (2001). Curr. Opin. Oncol., 13, 129-136.
27. Hayward N. (2000). Curr. Oncol. Rep., 2, 300-306.
28. Herlyn M, Thurin J, Balaban G, Bennicelli JL, Herlyn D, Elder DE, Bondi E, Guerry D, Nowell P, Clark WH and Koproski H. (1985). Cancer Res., 45, 5670-5676.
29. Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA, Grosveld G and Sherr CJ. (1997). Cell, 91, 649-659.
30. Keller-Melchior R, Schmidt R and Piepkorn M. (1998). J. Invest. Dermatol., 110, 932-938.
31. Kennedy C, ter Huurne J, Berkhout M, Gruis N, Bastiaens M, Bergman W, Willemze R and Bavinck JN. (2001). J. Invest. Dermatol., 117, 294-300.
32. Kiyono T, Foster SA, Koop JI, McDougall JK, Galloway DA and Klingelhutz AJ. (1998). Nature, 396, 84-88.
33. Le Poole IC, Boissy RE, Sarangarajan R, Chen J, Forristal JJ, Sheth P, Westerhof W, Babcock G, Das PK and Saelinger CB. (2000). In Vitro Cell Dev. Biol. Anim., 36, 309-319.
34. Medrano EE, Yang F, Boissy R, Farooqui J, Shah V, Matsumoto K, Nordlund JJ and Park H-Y. (1994). Mol. Biol. Cell, 5, 497-509.
35. Mooi WJ and Krausz T. (1992). Biopsy Pathology of Melanocytic Disorders. Chapman & Hall Medical: London.
36. Ohtani N, Zebedee Z, Huot TJG, Stinson JA, Sugimoto M, Ohashi Y, Sharrocks AD, Peters G and Hara E. (2001). Nature, 409, 1067-1070.
37. Papp T, Pemsel H, Zimmermann R, Bastrop R, Weiss DG and Schiffmann D. (1999). J. Med. Genet., 36, 610-614.
38. Ramirez RD, Morales CP, Herbert B-S, Rohde JM, Passons C, Shay JW and Wright WE. (2001). Genes Dev., 15, 398-403.
39. Rizos H, Darmanian AP, Holland EA, Mann GJ and Kefford RF. (2001a). J. Biol. Chem., 276, 41424-41434.
40. Rizos H, Puig S, Badenas C, Malvehy J, Darmanian AP, Jimenez L, Mila M and Kefford RF. (2001b). Oncogene, 20, 5543-5547.
41. Rocco JW and Sidransky D. (2001). Exp. Cell Res., 264, 42-55.
42. Ruas M and Peters G. (1998). Biochim. Biophys. Acta, 1378, F115-F177.
43. Rudolph P, Schubert C, Tamm S, Heidorn K, Hauschild A, Michalska I, Majewski S, Krupp G, Jablonska S and Parwaresch R. (2000). Am. J. Pathol., 156, 1425-1432.
44. Sage J, Mulligan GJ, Attardi LD, Miller A, Chen S, Williams B, Theodorou and Jacks T. (2000). Genes Dev., 14, 3037-3050.
45. Serrano M, Lee H-W, Chin L, Cordon-Cardo C, Beach D and DePinho RA. (1996). Cell, 85, 27-37.
46. Serrano M, Lin AW, McCurrach ME, Beach D and Lowe SW. (1997). Cell, 88, 593-602.
47. Sharpless NE and DePinho RA. (1999). Curr. Opin. Genet. Dev., 9, 22-30.
48. Sherr CJ. (2001). Nat. Rev. Mol. Cell Biol., 2, 731-737.
49. Smalley KSM and Eisen TG. (2002). Melanoma Res., 12, 1-6.
50. Sviderskaya EV, Hill SP, Evans-Whipp TJ, Chin L, Orlow SJ, Easty DJ, Cheong SC, Beach D, DePinho RA and Bennett DC. (2002). J. Natl. Cancer Inst., 94, 446-454.
51. Sviderskaya EV, Gray-Schopfer VC, Hill SP, Smit NP, Evans-Whipp TJ, Bond J, Hill L, Bataille V, Peters G, Kipling D, Wynford-Thomas D and Bennett DC. (2003). J. Natl. Cancer Inst., 95, (In press).
52. Walker GJ, Flores JF, Glendening JM, Lin AH, Markl ID and Fountain JW. (1998). Genes Chromosomes Cancer, 22, 157-163.
53. Wei W, Hemmer RM and Sedivy JM. (2001). Mol. Cell. Biol., 21, 6748-6757.
54. Wong G and Pawelek J. (1975). Nature, 255, 644-646.
55. Wynford-Thomas D. (1999). J. Pathol., 187, 100-111.
56. Yavuzer U, Keenan E, Lowings P, Vachtenheim J, Currie G and Goding CR. (1995). Oncogene, 10, 123-134.
57. Zepter K, Häffner AC, Trefzer U and Elmets CA. (1995). J. Invest. Dermatol., 104, 755-762.